Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14676 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Rong-Liang Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Neuroprotective Agents, Erythropoietin, Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Themen: Schlaganfall
Abstract (Originalsprache)
Aim
To explore the neuroprotective effects of ARA290 and the role of β‐common receptor (βCR) in a mouse model of middle cerebral artery occlusion (MCAO).
Methods
This study included male C57BL/6J mice that underwent MCAO and reperfusion. The neuroprotective effect of ARA290 on MCAO‐induced brain injury was investigated using neurological function tests (Longa and modified neurological severity score). Cerebral infarction was examined by 2, 3, 5‐triphenyl tetrazolium chloride staining, neuronal apoptosis was assessed by immunofluorescence staining, blood parameters were measured using a flow cytometry‐based automated hematology analyzer, liquid chromatography with tandem mass spectrometry was used to identify the serum metabolomics signature, inflammatory cytokines and liver index were detected by commercially available kits, and the protein levels of the erythropoietin (EPO) receptor and βCR were measured by western blot.
Results
ARA290 exerted a qualitatively similar neuroprotective effect after MCAO as EPO. ARA290 significantly reduced neuronal apoptosis and the level of inflammatory cytokines in the brain tissue. However, ARA290's neuroprotective effect was significantly suppressed following the injection of siRNA against βCR.
Conclusion
ARA290 provided a neuroprotective effect via βCR in cerebral ischemic mice without causing erythropoiesis. This study provides novel insights into the role of ARA290 in ischemic stroke intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China.
- Emergency Department, Xuanwu Hospital of Capital Medical University, Beijing, China.
ORCID-Profile: Yu-Min Luo
Förderung
- Beijing Municipal Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wang, R. L., Yang, Z. H., Huang, Y. Y., Hu, Y., Wang, Y. L., Yan, F., Zheng, Y. M., Han, Z. P., Fan, J. F., Tao, Z., Zhao, H. P., Li, S. J., & Luo, Y. M. (2024). Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14676
Vancouver
Wang RL, Yang ZH, Huang YY, Hu Y, Wang YL, Yan F, et al. Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14676
BibTeX
@article{Wang2024,
author = {Wang, Rong-Liang and Yang, Zhen-Hong and Huang, Yu-You and Hu, Yue and Wang, Yi-Lin and Yan, Feng and Zheng, Yang-Min and Han, Zi-Ping and Fan, Jun-Fen and Tao, Zhen and Zhao, Hai-Ping and Li, Si-Jie and Luo, Yu-Min},
title = {Erythropoietin‐derived peptide ARA290 mediates brain tissue protection through the β‐common receptor in mice with cerebral ischemic stroke},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14676}
}
EUVIMED